Neurogene Inc. Other Noncash Income (Expense)
Neurogene Inc. (NGNE) reported Other Noncash Income (Expense) of $14.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2020-05-06
- Neurogene Inc. other noncash income (expense) for the quarter ending 2020-03-31 was $14.00K.
- Neurogene Inc. other noncash income (expense) for the quarter ending 2019-12-31 was $13.00K, a 92.61% decline year-over-year.
- Neurogene Inc. other noncash income (expense) for the quarter ending 2019-09-30 was -$121.00K.
- Neurogene Inc. other noncash income (expense) for the quarter ending 2019-06-30 was -$143.00K.
- Neurogene Inc. other noncash income (expense) for fiscal 2019 was -$263.00K.
- Neurogene Inc. other noncash income (expense) for fiscal 2018 was -$452.00K.
- Neurogene Inc. other noncash income (expense) for fiscal 2017 was -$349.00K.
- Neurogene Inc. other noncash income (expense) for fiscal 2016 was -$185.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-03-31 | $14.00K 10-Q · filed 2020-05-06 | $27.00K derived: sum of 2 quarters · filed 2020-05-06 | -$94.00K derived: sum of 3 quarters · filed 2020-05-06 | -$237.00K derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$108.00K derived: sum of 2 quarters · filed 2020-03-12 | -$251.00K derived: sum of 3 quarters · filed 2020-03-12 | -$263.00K 10-K · filed 2020-03-12 | ||
| 2019-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$264.00K derived: sum of 2 quarters · filed 2019-11-13 | -$276.00K 10-Q · filed 2019-11-13 | -$100.00K derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$155.00K 10-Q · filed 2019-08-01 | $21.00K derived: sum of 3 quarters · filed 2020-05-06 | -$285.00K derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-03-31 | -$12.00K 10-Q · filed 2020-05-06 | -$74.00K 10-Q · filed 2019-05-07 | $164.00K derived: sum of 2 quarters · filed 2020-05-06 | -$142.00K derived: sum of 3 quarters · filed 2020-05-06 | -$332.00K derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$130.00K derived: sum of 2 quarters · filed 2020-03-12 | -$320.00K derived: sum of 3 quarters · filed 2020-03-12 | -$452.00K 10-K · filed 2020-03-12 | -$741.00K 10-K · filed 2019-03-07 | |
| 2018-09-30 | -$306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$496.00K derived: sum of 2 quarters · filed 2019-11-13 | -$628.00K 10-Q · filed 2019-11-13 | -$496.00K derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$322.00K 10-Q · filed 2019-08-01 | -$190.00K derived: sum of 3 quarters · filed 2020-03-12 | -$400.00K derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | -$132.00K 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | -$210.00K derived: sum of 3 quarters · filed 2020-03-12 | -$335.00K derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2017-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$78.00K derived: sum of 2 quarters · filed 2020-03-12 | -$203.00K derived: sum of 3 quarters · filed 2020-03-12 | -$349.00K 10-K · filed 2020-03-12 | -$709.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$335.00K derived: sum of 2 quarters · filed 2018-11-07 | -$481.00K 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$271.00K 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | -$146.00K 10-Q · filed 2018-05-08 | |||||
| 2016-12-31 | -$185.00K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |